# Narration and storyboard draft: Menopause Hormones: Symptoms, Prevention and Testosterone

Authored draft, approximately 60–90 seconds; no rendered video claimed.

Menopause hormones are several scientific questions. For women who begin with bothersome hot flushes, systemic hormone therapy reduces symptoms beyond placebo. Our HSEF assessment of that exact clinical claim is zeta, with high confidence. Randomized trials measure symptom relief, and laboratory experiments detect physiological changes beyond symptom diaries. That result does not establish dementia or cardiovascular prevention. Older oral-regimen WHI and WHIMS outcomes, modern timing studies and observational hormone users answer different questions with different limitations. Testosterone is separate again: controlled trials support a modest sexual-function benefit in diagnosed postmenopausal hypoactive sexual desire disorder. A selective cognitive-task signal and high-dose muscle effects cannot become a general promise of energy, cognition and strength. Consensus helped locate and cross-check source aspects, but its automated date filter missed important older originals. Our evidence cards retain those studies, their access limits and linked corrections. The next useful studies combine objective symptoms, credible blinding and prospective baseline contexts, while testing long-term prevention and harms separately.

1. Show the exact claim, grade and confidence.
2. Show selected publication milestones; label experimental systems and clinical endpoints.
3. Contrast the strongest result with its source-specific limitation.
4. End with the boundary experiment and primary-source links.

Use authored schematics; do not depict Consensus meters as causal confidence or reproduce publisher graphics without appropriate permission.